Tuberculosis trials in Zimbabwe
5 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.
- Phase 1/2Taking peopleA Study of Daily Rifapentine Combined With Isoniazid (1HP) for Tuberculosis Prevention in Children Less Than 13 Years of Age With and Without HIV
- Where
- Chitungwiza, Harare, Seke North
- Age
- Up to 13 years
- People
- 144 worldwide
- Run by
- National Institute of Allergy and Infectious Diseases (NIAID)
See details and how to joinNCT07124559 - Phase 3Taking peopleOptimal Treatment Duration for Radiographically Apparent, Bacteriologically Unconfirmed TB, Identified Through Active Case Finding (RADIO-TB Trial)
- Where
- Bulawayo
- Age
- 16 years and over
- People
- 784 worldwide
- Run by
- University College, London
See details and how to joinNCT07163143 - Phase 2Not yet taking people in ZimbabweA Trial of Stratified Patient-Centered Treatment Regimens for Active TB (SPECTRA-TB)
- Where
- Harare
- Age
- 13 years and over
- People
- 900 worldwide
- Run by
- National Institute of Allergy and Infectious Diseases (NIAID)
See details and how to joinNCT07595042 - Phase 3Taking peopleShortened Regimen for Drug-susceptible TB in Children
- Where
- Harare
- Age
- 0 days to 9 years
- People
- 860 worldwide
- Run by
- Johns Hopkins University
See details and how to joinNCT06253715 - Phase 2Taking peopleTrial of a Six-Month Regimen of High-Dose Rifampicin, High-Dose Isoniazid, Linezolid, and Pyrazinamide Versus a Standard Nine-Month Regimen for the Treatment of Adults and Adolescents With Tuberculous Meningitis
- Where
- Harare
- Age
- 15 years and over
- People
- 330 worldwide
- Run by
- National Institute of Allergy and Infectious Diseases (NIAID)
See details and how to joinNCT05383742